(Q37282694)

19 August 2017

Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis (English)

1 reference

19 August 2017

0 references

1 reference

1 reference

6

William R Bishai

1 reference

19 August 2017

7

Jacques H Grosset

1 reference

19 August 2017

8

Eric L Nuermberger

1 reference

19 August 2017

Ian M Rosenthal

1

1 reference

19 August 2017

Kathy Williams

2

1 reference

19 August 2017

Sandeep Tyagi

3

1 reference

19 August 2017

Andrew A Vernon

4

1 reference

19 August 2017

Charles A Peloquin

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

19 August 2017

1 reference

19 August 2017

172

1 reference

19 August 2017

11

1 reference

19 August 2017

1457-1462

1 reference

Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718441

Combination therapy for chronic obstructive pulmonary disease: clinical aspects

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.200507-1072OC

Development of rifapentine: the way ahead

21 January 2018

1 reference

12 December 2020

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium

1 reference

12 December 2020

A nested case-control study on treatment-related risk factors for early relapse of tuberculosis

1 reference

12 December 2020

In the treatment of tuberculosis, you get what you pay for...

1 reference

12 December 2020

1 reference

12 December 2020

10.1164/RCCM.200507-1072OC

Identifiers

DOI

1 reference

release_7nqtllfmvbanjod3djkvr4o5xq

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7nqtllfmvbanjod3djkvr4o5xq

24 November 2022

mapped directly with Wikidata item

1 reference

19 August 2017

PubMed publication ID

16141439

1 reference